ReviewJournal of immunology research2026
Allergic Sensitization to Common Ragweed and Mugwort Pollen Allergens: A 6-Year Single-Center Retrospective Analysis.
Review in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Allergic Sensitization to Common Ragweed and Mugwort Pollen Allergens: A 6-Year Single-Center Retrospective Analysis.Journal of immunology research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveBased on a 6-year longitudinal monitoring of specific immunoglobulin E (sIgE) responses to common ragweed (Ambrosia, Ambrosia artemisiifolia) and mugwort (Artemisia, Artemisia vulgaris) pollen allergens, this study systematically analyzed the sensitization trends of these two prevalent aeroallergen sources. The findings aim to provide evidence-based references for effective screening, early prevention, and targeted intervention in high-risk populations.
methodsThis study retrospectively analyzed the test results of 2798 patients who underwent both common ragweed pollen-sIgE and mugwort pollen-sIgE testing at Beijing Tsinghua Changgung Hospital from January 2020 to December 2025. It explored the sensitization characteristics of these two allergens across different time periods, age groups, and genders and performed a comparative analysis of their sensitization profiles.
resultsThe case volume peaked in 2025, followed by 2022. The positive rates of common ragweed and mugwort pollen-sIgE exhibited a decreasing trend from 2020 to 2024, yet rebounded in 2025. The highest positive rate was observed in the 6-15 years age group, with the overall positive rate showing a downward trend as age increased. The number of male patients was significantly higher than that of female patients (χ
conclusionsIn 2025, the positive rates of common ragweed pollen-sIgE and mugwort pollen-sIgE in the Beijing area exhibited a rebound trend. Positive rates of common ragweed and mugwort pollen-sIgE decreased with increasing age, whereas they were significantly higher in males than in females. Mugwort pollen allergens demonstrated stronger allergenicity than common ragweed pollen allergens; nevertheless, the two allergens showed highly consistent sensitization trends. These findings also corroborate the cross-reactivity between common ragweed and mugwort pollen allergens documented in the literature. However, further investigations are warranted to characterize the specific cross-reactive components and to develop novel diagnostic reagents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.